RGEN
RGEN
NASDAQ · Life Sciences Tools & Services

Repligen Corp

Mid-Cap Stocks Healthcare Stocks
$126.37
-0.20 (-0.16%)
As of Jun 23, 9:47 PM ET ·
Analyst Consensus
Strong Buy
28
Analysts
High
Coverage
Buy 23 82%
Hold 5 18%
Sell 0 0%
Price Target
Analyst Price Target -50.9% upside
Low Target $40.44
Average Target $62.10
High Target $74.58
Current Price $126.37
Current
$126.37
Target
$62.10
$40.44 $62.10 avg $74.58
Scenario Analysis
Bear Case
$40.44
-68.0%
Low target
Base Case
$62.10
-50.9%
Avg target
Bull Case
$74.58
+-41.0%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$175.77
-28.1% from high
52-Week Low
$100.99
+25.1% from low
50-Day SMA
$157.63
-19.8% vs SMA
200-Day SMA
$139.06
-9.1% vs SMA
RSI (14)
28.0
Oversold
Target vs 52W High
$62.10
-64.7% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
 Strong Buy 34 85% $369.21 -21.3%
DHR
Danaher Corp
 Strong Buy 30 90% $158.11 -11.7%
A
Agilent Technologies Inc
 Strong Buy 28 79% $64.69 -48.9%
WAT
Waters Corp
 Buy 28 57% $189.60 -46.9%
IQV
Iqvia Holdings Inc
 Strong Buy 30 80% $82.96 -51.6%
ILMN
Illumina Inc
 Buy 28 61% $169.36 +2.7%
WST
West Pharmaceutical Services
 Strong Buy 22 82% $136.24 -59.5%
MTD
Mettler-Toledo International
 Hold 20 50% $170.43 -85.3%